Robert Alexander - May 15, 2025 Form 4 Insider Report for Allakos Inc. (ALLK)

Role
Chief Executive Officer, Director
Signature
/s/ H. Baird Radford, III, by power of attorney
Stock symbol
ALLK
Transactions as of
May 15, 2025
Transactions value $
$0
Form type
4
Date filed
5/15/2025, 04:00 PM
Previous filing
Mar 7, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Alexander Robert Chief Executive Officer, Director 149 COMMONWEALTH DR, SUITE 1090, MENLO PARK /s/ H. Baird Radford, III, by power of attorney 2025-05-15 0001608782

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALLK Common Stock Disposed to Issuer -738K -100% 0 May 15, 2025 Direct F1, F2
transaction ALLK Common Stock Disposed to Issuer -320K -100% 0 May 15, 2025 See footnote F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALLK Stock Option (right to buy) Disposed to Issuer $0 -913K -100% $0.00 0 May 15, 2025 Common Stock 913K $0.69 Direct F4
transaction ALLK Stock Option (right to buy) Disposed to Issuer $0 -290K -100% $0.00 0 May 15, 2025 Common Stock 290K $4.01 Direct F4
transaction ALLK Stock Option (right to buy) Disposed to Issuer $0 -307K -100% $0.00 0 May 15, 2025 Common Stock 307K $4.31 Direct F4
transaction ALLK Stock Option (right to buy) Disposed to Issuer $0 -250K -100% $0.00 0 May 15, 2025 Common Stock 250K $35.28 Direct F4
transaction ALLK Stock Option (right to buy) Disposed to Issuer $0 -462K -100% $0.00 0 May 15, 2025 Common Stock 462K $7.20 Direct F4
transaction ALLK Stock Option (right to buy) Disposed to Issuer $0 -2M -100% $0.00 0 May 15, 2025 Common Stock 2M $1.25 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Robert Alexander is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Includes 292,810 shares represented by restricted stock units ("RSUs"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of the Issuer.
F2 Disposed of pursuant to the terms of that certain Agreement and Plan of Merger, dated April 1, 2025, by and among the Issuer, Concentra Biosciences, LLC and Concentra Merger Sub III, Inc. (the "Merger Agreement") in exchange for $0.33 in cash per share.
F3 The shares are held by Mr. Alexander and Stacey Lee Alexander, as Trustees of the Alexander 2018 Irrevocable Descendants' Trust.
F4 This option was cancelled without consideration pursuant to the terms of the Merger Agreement.